Felicity de Cogan
Overview
Explore the profile of Felicity de Cogan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
131
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Duca S, Nikoi N, Berrow M, Barber L, Slope L, Peacock A, et al.
Heliyon
. 2024 Aug;
10(15):e35109.
PMID: 39170441
Oligoarginine cell-penetrating peptides (CPPs) are short peptides that can enhance drug delivery into cells and are of particular interest in ocular topical formulations for age-related macular degeneration (AMD) treatments. The...
2.
Zhang J, Williams G, Jitniyom T, Singh N, Saal A, Riordan L, et al.
Langmuir
. 2024 Mar;
40(14):7353-7363.
PMID: 38536768
Nanomaterials of zinc oxide (ZnO) exhibit antibacterial activities under ambient illumination that result in cell membrane permeability and disorganization, representing an important opportunity for health-related applications. However, the development of...
3.
Bryant J, Riordan L, Watson R, Nikoi N, Trzaska W, Slope L, et al.
Glob Chall
. 2022 May;
6(5):2100138.
PMID: 35602408
There is an increasing focus in healthcare environments on combatting antimicrobial resistant infections. While bacterial infections are well reported, infections caused by fungi receive less attention, yet have a broad...
4.
Watson R, Oldfield M, Bryant J, Riordan L, Hill H, Watts J, et al.
Sci Rep
. 2022 Mar;
12(1):2803.
PMID: 35264599
The COVID-19 pandemic has demonstrated the real need for mechanisms to control the spread of airborne respiratory pathogens. Thus, preventing the spread of disease from pathogens has come to the...
5.
Nikoi N, Berwick M, Bryant J, Riordan L, Slope L, Peacock A, et al.
Curr Eye Res
. 2021 Apr;
46(5):751-757.
PMID: 33896277
Aim: The development of a polyarginine cell-penetrating peptide (CPP) could enable the treatment of age-related macular degeneration, with drugs like bevacizumab, to be administered using eye drops instead of intravitreal...
6.
Riordan L, Smith E, Mills S, Hudson J, Stapley S, Nikoi N, et al.
Mater Sci Eng C Mater Biol Appl
. 2019 Jun;
102:299-304.
PMID: 31147002
Despite increased sterilisation and education campaigns, hospital acquired infections have not been eradicated. Bacterial colonisation of frequent touch surfaces is key in the transmission of infection. Most current technologies cannot...
7.
Mohammed S, Chouhan G, Anuforom O, Cooke M, Walsh A, Morgan-Warren P, et al.
Mater Sci Eng C Mater Biol Appl
. 2017 Jun;
78:203-209.
PMID: 28575976
Microbial keratitis is a severe ocular condition and one of the most prevalent causes of corneal scarring and associated blindness worldwide. Risk factors include contact lens use, ocular trauma, ocular...
8.
de Cogan F, Hill L, Lynch A, Morgan-Warren P, Lechner J, Berwick M, et al.
Invest Ophthalmol Vis Sci
. 2017 May;
58(5):2578-2590.
PMID: 28494491
Purpose: To evaluate the efficacy of anti-VEGF agents for treating choroidal neovascularization (CNV) when delivered topically using novel cell-penetrating peptides (CPPs) compared with delivery by intravitreal (ivit) injection. Methods: CPP...
9.
Townsend L, Williams R, Anuforom O, Berwick M, Halstead F, Hughes E, et al.
J R Soc Interface
. 2017 Jan;
14(126).
PMID: 28077764
The interface between implanted devices and their host tissue is complex and is often optimized for maximal integration and cell adhesion. However, this also gives a surface suitable for bacterial...
10.
Morgan-Warren P, ONeill J, de Cogan F, Spivak I, Ashush H, Kalinski H, et al.
Invest Ophthalmol Vis Sci
. 2016 Feb;
57(2):429-43.
PMID: 26848882
Purpose: To investigate, using in vivo and in vitro models, retinal ganglion cell (RGC) neuroprotective and axon regenerative effects and underlying mechanisms of siRTP801, a translatable small-interfering RNA (siRNA) targeting...